QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.052027v1 306/3/1068    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kenny, P. J. Articles by Markou, A. Search for Related Content PubMed PubMed Citation Articles by Kenny, P. J. Articles by Markou, A.

NEUROPHARMACOLOGY

Group II Metabotropic and -Amino-3-hydroxy-5-methyl-4-isoxazole Propionate (AMPA)/Kainate Glutamate Receptors Regulate the Deficit in Brain Reward Function Associated with Nicotine Withdrawal in Rats

Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California (P.J.K., A.M.); and Nervous System Research, Novartis Biomedical Institutes, Basel, Switzerland (F.G.)

This study investigated the role of ionotropic and metabotropic glutamate receptors in the deficits in brain reward function, as measured by elevations in intracranial self-stimulation (ICSS) reward thresholds, associated with nicotine withdrawal. The group II metabotropic glutamate (mGluII) receptor agonist LY314582 [a racemic mixture of LY354740 ([+]-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid])] (2.5-7.5 mg/kg) precipitated withdrawal-like elevations in ICSS thresholds, a sensitive measure of reward function, in nicotine-dependent but not control rats. LY314582 did not affect response latencies, a measure of performance in the ICSS paradigm. Bilateral microinfusion of LY314582 (10-100 ng/side) into the ventral tegmental area likewise precipitated dose-dependent threshold elevations in nicotine-dependent rats. Furthermore, a single injection of the mGluII receptor antagonist LY341495 (2S-2-amino-2-[1S,2S-2-carboxycyclopropan-1-yl]-3-[xanth-9-yl]propionic acid) (1 mg/kg) attenuated the threshold elevations observed in rats undergoing spontaneous nicotine withdrawal. mGluII receptors are primarily located on glutamatergic terminals throughout the mesocorticolimbic system, where they act as inhibitory autoreceptors. To investigate whether mGluII receptors contributed to nicotine withdrawal by decreasing glutamatergic transmission, we next examined whether direct blockade of postsynaptic glutamate receptors precipitated withdrawal-like reward deficits in nicotine-dependent rats. The -amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX; 0.01-1 mg/kg) precipitated withdrawal-like threshold elevations in nicotine-dependent but not control rats, whereas 6-methyl-2-[phenylethynyl]-pyridine (MPEP; 0.01-3 mg/kg) and dizocilpine (MK-801; 0.01-0.2 mg/kg), antagonists at metabotropic glutamate 5 and N-methyl-D-aspartate receptors, respectively, did not. Overall, these data demonstrate that mGluII receptors play an important role in the reward deficits associated with nicotine withdrawal. Furthermore, it is likely that mGluII receptors generate this reward deficit, at least in part, by decreasing glutamate transmission at AMPA/kainate receptors.

Address correspondence to: Dr. Athina Markou, Department of Neuropharmacology, CVN-7, The Scripps Research Institute, 10550 North Torrey Pines Rd., La Jolla, CA 92037. E-mail: amarkou{at}scripps.edu

This article has been cited by other articles:

				M. De Biasi and R. Salas Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal Experimental Biology and Medicine, August 1, 2008; 233(8): 917 - 929. [Abstract] [Full Text] [PDF]

				M. E. Liechti, L. Lhuillier, K. Kaupmann, and A. Markou Metabotropic Glutamate 2/3 Receptors in the Ventral Tegmental Area and the Nucleus Accumbens Shell Are Involved in Behaviors Relating to Nicotine Dependence J. Neurosci., August 22, 2007; 27(34): 9077 - 9085. [Abstract] [Full Text] [PDF]

				Y.-Y. Huang and E. R. Kandel Low-frequency stimulation induces a pathway-specific late phase of LTP in the amygdala that is mediated by PKA and dependent on protein synthesis Learn. Mem., July 12, 2007; 14(7): 497 - 503. [Abstract] [Full Text] [PDF]

				P. J. Kenny, S. A. Chen, O. Kitamura, A. Markou, and G. F. Koob Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J. Neurosci., May 31, 2006; 26(22): 5894 - 5900. [Abstract] [Full Text] [PDF]

				M. F. Olive, A. J. Mcgeehan, J. R. Kinder, T. McMahon, C. W. Hodge, P. H. Janak, and R. O. Messing The mGluR5 Antagonist 6-Methyl-2-(phenylethynyl)pyridine Decreases Ethanol Consumption via a Protein Kinase C{epsilon}-Dependent Mechanism Mol. Pharmacol., February 1, 2005; 67(2): 349 - 355. [Abstract] [Full Text] [PDF]

				J. M. Bossert, S. Y. Liu, L. Lu, and Y. Shaham A Role of Ventral Tegmental Area Glutamate in Contextual Cue-Induced Relapse to Heroin Seeking J. Neurosci., November 24, 2004; 24(47): 10726 - 10730. [Abstract] [Full Text] [PDF]